Global Non-Invasive Prenatal Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313350
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Ariosa Diagnostics, Inc.
  • Berry Genomics Co., Ltd.
  • BGI Diagnostics
  • Illumina, Inc.
  • LifeCodexx AG
  • Natera, Inc.
  • MORE
Non-Invasive Prenatal Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022, the non-invasive prenatal testing market was valued at USD 613.0 Mn in 2015, and is expected to reach USD 1,939.9 Mn by 2022, expanding at a CAGR of 17.9% from 2016 to 2022.

Market Insights
The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure.

Non-invasive prenatal testing is defined as a highly sensitive screening process that assists in detecting chromosomal abnormalities in the fetus during pregnancy. Some of such chromosomal abnormal abilities that can be detected through NIPT are Down syndrome, Patau syndrome, Edwards’ syndrome and Turner syndrome.

Among the available NIPT tests, the MaternitT21 test is the largest segment and it is anticipated that its dominance will continue through 2022. It was the first test to receive approval for detection of Trisomy 21 in 2011. Other chromosomal abnormalities that could be detected with MaternitT21 are Wolf-Hirschhorn syndrome, DiGeorge syndrome, Langer-Giedion syndrome, 1q36 deletion syndrome and Jaconsen syndrome. MaterniT21 used cfDNA and parallel sequencing technology and delivers results in a 5 day period.

North America is the largest market for non-invasive prenatal testing. Emerging markets of Asia-Pacific and Latin America are growing at a significant growth rate, attributed by the growing awareness about chromosomal abnormalities, their prevention, growing population of late maternity age, and rapid development of healthcare infrastructure. However, ethical concerns associated with such tests is the most prominent market restraint.

The major players engaged in the global noninvasive prenatal testing market are LifeCodexx AG, Illumina, Inc., Sequenom, Inc. LABCORP, Natera, Inc. and others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ariosa Diagnostics, Inc.
  • Berry Genomics Co., Ltd.
  • BGI Diagnostics
  • Illumina, Inc.
  • LifeCodexx AG
  • Natera, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Non-Invasive Prenatal Testing Market, by Products, 2015 (USD Mn)
2.2 Non-Invasive Prenatal Testing Market Share, by Geography, 2015 (Value %)

Chapter 3 Non-Invasive Prenatal Testing Market: Market Dynamics and Outlook
3.1 Introduction
3.2 Major Commercial Events
3.3 Drivers
3.4 Challenges
3.5 Opportunities
3.6 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global Non-Invasive Prenatal Testing Market Analysis, by Products
4.1 Preface
4.2 Maternit21 Plus
4.3 Bambnitest
4.4 Informaseq Prenatal Test
4.5 Harmony Prenatal Test
4.6 Non-Invasive Fetal Trisomy (Nifty) Test
4.7 Verifi
4.8 Prenatest
4.9 Panorama Test
4.10 Visibilit Test

Chapter 5 Global Non-Invasive Prenatal Testing Market, by Geography
5.1 Preface
5.2 North America
5.2.1 U.S
5.2.2 Canada
5.3 Europe
5.3.1 U.K
5.3.2 Germany
5.3.3 Rest of Europe
5.4 Asia-Pacific
5.4.1 Japan
5.4.2 China
5.4.3 Rest of Asia-Pacific
5.5 Middle East and Africa (Mea)
5.6 Latin America

Chapter 6 Company Profiles
6.1 Ariosa Diagnostics, Inc
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 Berry Genomics Co., Ltd
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 Bgi Diagnostics
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Illumina, Inc
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Positions/Portfolio
6.4.4 News Coverage
6.5 Laboratory Corporation of America Holdings (Labcorp)
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Positions/Portfolio
6.5.4 News Coverage
6.6 Lifecodexx Ag
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Positions/Portfolio
6.6.4 News Coverage
6.7 Natera, Inc
6.7.1 Business Description
6.7.2 Financial Health and Budget Allocation
6.7.3 Product Positions/Portfolio
6.7.4 News Coverage
6.8 Sequenom, Inc
6.8.1 Business Description
6.8.2 Financial Health and Budget Allocation
6.8.3 Product Positions/Portfolio
6.8.4 News Coverage
6.9 Others
6.9.1 Business Description
6.9.2 Financial Health and Budget Allocation
6.9.3 Product Positions/Portfolio
6.9.4 News Coverage

List of Figures
Figure 1 Non-Invasive Prenatal Testing: Market Segmentation
Figure 2 Non-Invasive Prenatal Testing Market, by Products, 2015 (USD Mn)
Figure 3 Non-Invasive Prenatal Testing Market Share, by Geography, 2015 (Value %)
Figure 4 Attractive Investment Proposition, Non-Invasive Prenatal Testing Market, 2015
Figure 5 Competitive Analysis: Fractal Map Investigation, by Key Market Players
Figure 6 Global Maternit21 Plus Market, 2014 - 2022 (USD Mn)
Figure 7 Global Bambnitest Market, 2014 - 2022 (USD Mn)
Figure 8 Global Informaseq Prenatal Test Market, 2014 - 2022 (USD Mn)
Figure 9 Global Harmony Prenatal Test Market, 2014 - 2022 (USD Mn)
Figure 10 Global Non-Invasive Fetal Trisomy (Nifty) Test Market, 2014 - 2022 (USD Mn)
Figure 11 Global Verifi Market, 2014 - 2022 (USD Mn)
Figure 12 Global Prenatest Market, 2014 - 2022 (USD Mn)
Figure 13 Global Panorama Test Market, 2014 - 2022 (USD Mn)
Figure 14 Global Visibilit Test Market, 2014 - 2022 (USD Mn)
Figure 15 U.S. Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 16 Canada Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 17 U.K. Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 18 Germany Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 19 Rest of Europe Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 20 Japan Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 21 China Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 22 Rest of Asia-Pacific Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 23 Middle East and Africa Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)
Figure 24 Latin America Non-Invasive Prenatal Testing Market, 2014 - 2022 (USD Mn)

List of Tables
Table 1 Global Non-Invasive Prenatal Testing Market, by Products, 2014 - 2022 (USD Mn)
Table 2 Global Non-Invasive Prenatal Testing Market, by Geography, 2014 - 2022 (USD Mn)
Table 3 North America Non-Invasive Prenatal Testing Market, by Country, 2014 - 2022 (USD Mn)
Table 4 Europe Non-Invasive Prenatal Testing Market, by Country, 2014 - 2022 (USD Mn)
Table 5 Asia-Pacific Non-Invasive Prenatal Testing Market, by Country, 2014 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ariosa Diagnostics, Inc.
  • Berry Genomics Co., Ltd.
  • BGI Diagnostics
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • LifeCodexx AG
  • Natera, Inc.
  • Sequenom, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll